Investor Hotline: 877-5676-CRL
Accelerating Drug Development. Exactly. Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our more than 9,000 employees worldwide are focused on providing clients with exactly what they need to improve and expedite the discovery, development through first-in-human evaluation, and safe manufacture of new therapies for the patients who need them.
 |
News Releases
| Date | Title | | | 11/19/08 | Charles River Promotes Foster Jordan to Corporate Senior Vice President| WILMINGTON, Mass., Nov 19, 2008 (BUSINESS WIRE) -- Charles River Laboratories International, Inc. (NYSE: CRL) today
announced the promotion of Foster Jordan to Corporate Senior Vice
President, Endotoxin & Microbial Detection Products.
"With Foster's direction our in vitro solutions are market leaders and
pillars in the Company's success. His ability to anticipate both
industry and customer demands will help drive the continued growth and
profitability of ... |
|  | | 11/10/08 | Charles River Reschedules 2009 Guidance Release| WILMINGTON, Mass.--(BUSINESS WIRE)--Nov. 10, 2008--Charles River
Laboratories International, Inc. (NYSE: CRL) today announced that it
has elected to defer guidance for fiscal 2009 until it announces its
2008 fourth-quarter and full-year results, tentatively scheduled for
release on February 9, 2009. The Company, which last week said it had
originally intended to provide 2009 guidance on December 10, said that
it believes there will be greater visibility in terms of customer
commitment... |
| | | 11/05/08 | Charles River Announces Third-Quarter 2008 Results|
Downloadable version.
Third-Quarter Sales Increase 9.0% to $342 Million
Third-Quarter GAAP EPS Increase 1.6% to $0.63 and Non-GAAP EPS
Increase 10.1% to $0.76
Company Updates 2008 Guidance
WILMINGTON, Mass.--(BUSINESS WIRE)--Nov. 5, 2008--Charles River
Laboratories International, Inc. (NYSE: CRL) today reported its
results for the third quarter and first nine months of 2008. For the
quarter, net sales increased 9.0% t... |
| | | 10/30/08 | Charles River Adds Veterinary School Dean Dr. Deborah Kochevar to Board of Directors| WILMINGTON, Mass.--(BUSINESS WIRE)--Oct. 30, 2008--Charles River
Laboratories International, Inc. (NYSE: CRL) today announced that Dr.
Deborah Kochevar, Dean of the Cummings School of Veterinary Medicine
at Tufts University, was elected to the Company's Board of Directors.
Dr. Kochevar's extensive scientific and veterinary expertise will be
an asset to the board as it identifies new opportunities to further
enhance the Company's unique portfolio of essential drug discovery and
develop... |
| |
|
|
Upcoming Events
| There are currently no events scheduled. |
